AstraZeneca working on vaccine with Oxford to target new variant, CEO says - La Repubblica

FILE PHOTO: Vial and sryinge are seen in front of displayed AstraZeneca logo

(Reuters) - AstraZeneca Chief Executive Pascal Soriot said on Tuesday that the British drugmaker is working with Oxford University on a vaccine that will target the South African variant of COVID-19.

"Having said that, we're also working on a vaccine with Oxford University that will target the variant," Soriot told Italian daily La Repubblica in an interview published late on Tuesday.

(Reporting by Kanishka Singh in Bengaluru; Editing by Leslie Adler)